UY27510A1 - COMBINATION THERAPY - Google Patents
COMBINATION THERAPYInfo
- Publication number
- UY27510A1 UY27510A1 UY27510A UY27510A UY27510A1 UY 27510 A1 UY27510 A1 UY 27510A1 UY 27510 A UY27510 A UY 27510A UY 27510 A UY27510 A UY 27510A UY 27510 A1 UY27510 A1 UY 27510A1
- Authority
- UY
- Uruguay
- Prior art keywords
- combinations
- atorvastatin
- refers
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Refiere combinaciones farmacéuticas de atorvastatina o sal farmacéuticamente aceptable de la misma y agentes antihipertensorers, estuches de ensayo que contienen dichas combinaciones y procedimiento para itilizar dichas combinaciones para tratar sujetos que sufren de angina pectoris, ateroesclorosis, hipertensión e hiperlipidemia combinadas y para tratar sujetos que presenten síntomas de riesgo cardíaco, incluyendo seres humanos. Refiere también combinaciones aditivas y sinérgicas de atorvastatina o sal farmacéuticamente aceptable de la misma y agentes antihipertensores por los que estas combinaciones sinérgicas son útiles en el tratamiento de sujetos como los antes sugeridos.It refers to pharmaceutical combinations of atorvastatin or pharmaceutically acceptable salt thereof and antihypertensorers agents, test kits containing said combinations and procedure to similarize said combinations to treat subjects suffering from angina pectoris, atherosclorosis, hypertension and hyperlipidemia combined and to treat subjects presenting Heart risk symptoms, including humans. It also refers to additive and synergistic combinations of atorvastatin or pharmaceutically acceptable salt thereof and antihypertensive agents for which these synergistic combinations are useful in the treatment of subjects such as those suggested above.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UY27510A UY27510A1 (en) | 2002-10-22 | 2002-10-22 | COMBINATION THERAPY |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UY27510A UY27510A1 (en) | 2002-10-22 | 2002-10-22 | COMBINATION THERAPY |
Publications (1)
Publication Number | Publication Date |
---|---|
UY27510A1 true UY27510A1 (en) | 2004-05-31 |
Family
ID=38812707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY27510A UY27510A1 (en) | 2002-10-22 | 2002-10-22 | COMBINATION THERAPY |
Country Status (1)
Country | Link |
---|---|
UY (1) | UY27510A1 (en) |
-
2002
- 2002-10-22 UY UY27510A patent/UY27510A1/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY25155A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ATORVASTATINE AND AN ANTI-HYPERTENSIVE AGENT | |
CO4970694A1 (en) | AMLODIPINE AND ATORVASTATINE USEFUL IN THE TREATMENT OF ANGINA BREAST, Atherosclerosis, hypertension and hyperlipidemia | |
CY1117925T1 (en) | METHOD OF EDUCATION AND BIOPODIFICATION RELATING TO INHIBITORS OF INFLUENCE OF MIGRATORY MIGRATION (MIF) AS A PROCESSED FROM PROCEDURE | |
CO4970726A1 (en) | COMBINATION PINE AND ATORVASTATINE THERAPY USEFUL IN THE TREATMENT OF CHEST ANGINA, ATHEROSCLEROSIS, HYPERTENSION AND HYPERLIPIDEMIA | |
EA200800356A1 (en) | TREATING CHOLESTEROL ABSORPTION WITH AZETIDINONE AND OMEGA-3 INHIBITOR WITH FATTY ACIDS AND THEIR COMBINED DRUG | |
ECSP045520A (en) | TREATMENT METHODS WITH PTEC INHIBITORS AND ANTIHIPERTENSIVE AGENTS | |
EA200900802A1 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID DISEASES | |
ATE547420T1 (en) | AZEPINOINDOLE AND PYRIDOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS | |
EA200600078A1 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID DISEASES | |
AR054094A1 (en) | CANCER TREATMENTS | |
GT200600163A (en) | NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION | |
BRPI0517481A (en) | method for treating, controlling or preventing a protozoan parasitic disease or disorder, and, pharmaceutical composition | |
EA200870127A1 (en) | POLYCYCLIC DERIVATIVES OF AMINO ACIDS AND METHODS OF THEIR APPLICATION | |
NO20055863L (en) | W-carboxyaryl-substituted diphenylurea compounds as raf kinase inhibitors | |
UY26130A1 (en) | COMPOUNDS TO TREAT OBESITY | |
CY1110162T1 (en) | PHARMACEUTICAL FORM AND METHODS FOR THE TREATMENT OF THROMBOCYTALARIA | |
ATE527251T1 (en) | BICYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS | |
NI200200095A (en) | "PHARMACEUTICAL COMPOSITIONS OF AMLODIPINE AND ATORVASTATIN" | |
EA200500244A1 (en) | TETRAPROPILAMMONIA TETRATIOMOLYBDAT AND RELATED COMPOUNDS FOR ANTIANGIOGENIC THERAPY | |
UY31417A1 (en) | A PHARMACEUTICAL COMPOSITION AND A PROCESS FOR SUCH PHARMACEUTICAL COMPOSITION | |
EA200700403A1 (en) | TRICYCLIC δ-OPIOID MODULATORS | |
CY1118486T1 (en) | LAPATINIBE FOR CANCER TREATMENT | |
ECSP077169A (en) | METHODS TO IMPROVE THE BIODISPONIBILITY OF A RENINA INHIBITOR | |
UY27510A1 (en) | COMBINATION THERAPY | |
EA200601392A1 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF LIPODYSTROPHY |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20160616 |